AI Summary RFA is a minimally invasive, image-guided procedure that uses heat from radiofrequency energy to destroy small liver tumors and can be curative in carefully selected patients.
Medically reviewed.
Radiofrequency ablation (RFA) is a minimally invasive, image-guided procedure that uses heat generated by radiofrequency energy to destroy liver tumors. It is most often used for small tumors and can be curative in carefully selected patients. A probe is inserted directly into the tumor to deliver thermal energy, destroying cancer cells while preserving surrounding healthy liver tissue. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers RFA's role in liver tumor treatment — how it works, who may be eligible, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether RFA fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT RFA TREATMENT
Radiofrequency ablation (RFA) is a minimally invasive, image-guided procedure that destroys liver tumors using heat generated by radiofrequency energy. A needle-like probe is inserted directly into the tumor, and radiofrequency energy delivered through the probe generates heat that destroys cancer cells through thermal injury while preserving the surrounding healthy tissue.
RFA is most often used for small liver tumors and can be curative in carefully selected patients. Unlike non-thermal techniques such as histotripsy, which uses focused ultrasound to mechanically break down tumor cells, RFA relies on thermal energy to achieve local tumor destruction.
RFA is typically performed by trained specialists under imaging guidance, alongside ongoing monitoring and, when appropriate, other liver-directed or systemic cancer therapies.
WHO RFA MAY BE SUITABLE FOR
Eligibility for RFA depends on your tumor characteristics, overall liver function, and treatment goals. Your healthcare provider may recommend RFA if you have small liver tumors, are not a candidate for surgery, require localized tumor treatment, or need a potentially curative treatment option for early-stage disease.
RFA may also be considered when your healthcare provider determines the tumor is accessible for ablation. Locoregional therapies like RFA are generally recommended based on the size, number, and location of liver tumors, as well as overall liver function.
Because every patient's tumor and liver condition is different, there is no one-size-fits-all answer to who should have RFA. Your healthcare provider determines whether thermal ablation is an appropriate option after a full assessment of your liver disease and treatment goals.
ELIGIBILITY OVERVIEW
RFA may be considered for adults with the following conditions, needs, or treatment goals:
Before recommending RFA, healthcare providers evaluate several factors to determine whether it is an appropriate option, including:
HOW RFA CAN HELP YOUR LIVER
RFA uses a needle-like probe to deliver radiofrequency energy directly into a liver tumor. Imaging studies such as ultrasound, CT, or MRI are used beforehand to locate the tumor and plan treatment, and the probe is then advanced through the skin into the tumor under imaging guidance.
Once in place, the probe delivers radiofrequency energy that generates heat, destroying cancer cells through thermal injury. Because the energy is tightly focused on the tumor, RFA is designed to preserve the surrounding healthy liver tissue while providing local tumor control.
RFA is performed by trained specialists under imaging guidance. Long-term management after treatment depends on how the tumor responds, the stage of disease, and whether additional liver-directed or systemic therapies are needed.
LIVER BENEFITS
RFA delivers heat directly into a liver tumor and destroys cancer cells through thermal injury. This gives local tumor control, which means the treatment targets the lesion itself rather than the whole liver.
Because the heat is focused on the tumor, RFA is designed to preserve the healthy tissue around it. Leaving more of the liver intact is an important goal for people who already live with liver disease.
RFA is most often used for small liver tumors. In carefully selected patients with early-stage disease, it can be curative and may eradicate the tumor entirely.
RFA is typically a single-session procedure, and additional sessions may be performed if needed based on how the tumor responds. Follow-up imaging confirms that the ablation worked and checks for tumor recurrence, so your healthcare team can adjust your care and keep protecting your liver.
RFA supports liver health by destroying small tumors at their source while preserving healthy liver tissue, and by offering a minimally invasive path to possible cure in early-stage disease. Repeat treatment when needed and follow-up imaging help keep tumors under control. Your healthcare team decides whether it fits your situation.
TREATMENT PROCESS
Before the procedure, your healthcare team reviews imaging studies such as ultrasound, CT, or MRI to locate the tumor precisely, measure its size, and confirm it is accessible for ablation. This planning step also helps the team choose the safest path for the probe and estimate how large a treatment zone is needed to cover the tumor.
On the day of treatment, a needle-like probe is inserted through the skin and advanced directly into the tumor. The entire path of the probe is tracked in real time using imaging guidance, which allows the team to confirm correct placement before energy is delivered.
Once the probe is in place, radiofrequency energy is delivered through it, generating heat that destroys the targeted tumor tissue through thermal injury. The treatment team controls the energy delivery to create a zone of destruction that covers the tumor plus a small margin of surrounding tissue.
Most patients experience a relatively short recovery period and may return home the same day or after a brief observation period. You may be advised to rest and avoid strenuous activity for a short time afterward.
RFA is typically a single-session procedure, though additional sessions may be performed if needed based on how the tumor responds to the initial treatment.
Follow-up imaging studies are performed at scheduled intervals after treatment to confirm successful ablation and monitor for tumor recurrence, guiding decisions about any further treatment.
BENEFITS AND SAFETY
RFA may support people with small, accessible liver tumors by destroying tumor cells through thermal injury, without the need for major surgery. Because the treatment is minimally invasive and tightly focused, it can offer local tumor destruction while preserving surrounding healthy liver tissue, and in carefully selected patients with early-stage disease, it can be curative. The extent of these benefits varies from person to person, depending on tumor size, location, and overall liver function.
RFA is not a stand-alone treatment — it works best as part of a broader, personalized care plan that may include imaging-based monitoring and, when appropriate, other liver-directed or systemic cancer therapies.
As with any procedure, RFA may cause side effects, ranging from mild discomfort near the treatment area to temporary changes in liver enzyme levels. Your healthcare provider will monitor your treatment response and liver function through follow-up imaging and clinical assessments.
BENEFITS
RFA does not require major surgery. The probe is inserted through the skin rather than through a surgical incision, offering a minimally invasive way to treat small, accessible liver tumors while avoiding the risks associated with open or laparoscopic surgery.
RFA delivers thermal energy directly into the tumor under imaging guidance, providing effective local destruction of targeted lesions while limiting the treatment's effect on the surrounding healthy liver.
In carefully selected patients with small, early-stage tumors, RFA may eradicate the tumor entirely.
Because it is minimally invasive, RFA typically involves a shorter recovery time compared with surgery, and many patients return home the same day or after a brief observation period.
These effects are often mild and temporary. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support, including follow-up imaging, to monitor treatment response.
SUPPORTING YOUR RESULTS
Lifestyle changes are an important part of a comprehensive treatment plan alongside RFA. Avoiding heavy lifting for a short period, eating a liver-friendly diet, and avoiding alcohol may all play a role in supporting your results.
Keeping to your follow-up imaging schedule also helps your healthcare provider confirm successful ablation and monitor for tumor recurrence, supporting long-term outcomes.
Areas that may support treatment:
COMMON QUESTIONS
In carefully selected patients with small, early-stage liver tumors, RFA can be curative and may eradicate the tumor. Whether it offers a lasting benefit depends on tumor size, number, and location, whether the tumor is accessible for ablation, and your overall liver function. Follow-up imaging confirms whether the ablation worked. Talk with your healthcare provider about realistic goals for your treatment plan.
RFA may be recommended if you have small liver tumors, are not a candidate for surgery, need localized tumor treatment, or need a potentially curative option for early-stage disease. Your healthcare provider must also determine that the tumor is accessible for ablation. This decision follows a review of your imaging, tumor characteristics, overall liver function, and treatment goals.
RFA destroys tumor cells with heat. A needle-like probe is inserted through the skin and guided into the tumor using imaging. Radiofrequency energy delivered through the probe generates heat that destroys cancer cells through thermal injury. Because the energy is focused on the tumor, RFA is designed to preserve the surrounding healthy tissue. This differs from non-thermal techniques such as histotripsy, which uses focused ultrasound to mechanically break down tumor cells without heat.
Recovery is usually short. Most patients return home the same day or after a brief observation period. You may be advised to rest and avoid strenuous activity for a short time, and to avoid heavy lifting for a short period after the procedure. Your healthcare team will tell you how long to limit activity based on your situation.
The most common side effects are pain at the treatment site, fatigue, fever, mild abdominal discomfort, and a temporary rise in liver enzymes. These effects are often mild and temporary. Your healthcare provider will discuss the potential benefits and risks with you before treatment and monitor your response with follow-up imaging and clinical assessments.
Probably not. RFA is typically a single-session procedure. Your healthcare provider may perform additional sessions if needed, based on how the tumor responds to the first treatment. Follow-up imaging shows how the tumor has responded and guides any decision about further treatment.
You will have follow-up imaging at scheduled intervals to confirm the ablation worked and to watch for tumor recurrence. Keeping to that schedule is the most important step, because the results guide any further treatment. You are also advised to avoid alcohol, follow a liver-friendly eating pattern, and avoid heavy lifting for a short period. Ask your healthcare team about any other limits that apply to you.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
